Skip to main content
. 2012 Nov 5;287(52):43370–43377. doi: 10.1074/jbc.M112.408906

TABLE 3.

Analysis of stabilization of OLF variants by Ca2+

Variant Rationale Tm Tm + 10 mm CaCl2 ΔTm
°C °C °C
myoc-OLF Wild-type 53.0 ± 0.5 59.6 ± 0.2 6.6
myoc-OLF core Identified structural corea 49.7 ± 0.3 57.7 ± 0.1 8.1
MBP-OLF(G246R) Disease-causing variant 42.5 ± 0.2 50.6 ± 0.0 8.1
MBP-OLF(G252R) Disease-causing variant 43.0 ± 0.2 51.5 ± 0.2 8.5
MBP-OLF(R272G) Disease-causing variant 41.0 ± 0.3 48.6 ± 0.1 7.6
MBP-OLF(D273A) Carboxylate side chain? 21.7 ± 0.8 21.1 ± 0.7 −0.6
MBP-OLF(E323K) Disease-causing variant 44.0 ± 0.5 50.3 ± 0.2 6.2
MBP-OLF(G364V) Disease-causing variant 45.0 ± 0.4 51.9 ± 0.1 6.9
MBP-OLF(G367R) Disease-causing variant 42.7 ± 0.1 50.9 ± 0.4 8.1
MBP-OLF(T377M) Disease-causing variant 44.3 ± 0.3 50.6 ± 0.6 6.3
MBP-OLF(D378A) Carboxylate side chain? N/A N/A N/Ab
MBP-OLF(D380A) Carboxylate side chain ligand? and disease causing variant 46.6 ± 0.3 45.1 ± 0.5 −1.5
MBP-OLF(D384A) Carboxylate side chain ligand? 42.5 ± 0.7 53.6 ± 0.5 11.1
MBP-OLF(E385A) Carboxylate side chain ligand? 39.7 ± 0.4 49.7 ± 0.3 10
MBP-OLF(K423E) Disease-causing variant 34.2 ± 0.4 43.2 ± 0.1 9.0
MBP-OLF(V426F) Disease-causing variant 41.5 ± 0.1 49.9 ± 0.1 8.4
MBP-OLF(A427T) Disease-causing variant 48.3 ± 0.3 55.2 ± 0.4 6.9
MBP-OLF(C433R) disease causing variant 40.4 ± 0.4 49.4 ± 0.5 9.0
MBP-OLF(Y437H) Disease-causing variant 40.3 ± 0.4 48.6 ± 0.2 8.3
MBP-OLF(I477N) Disease-causing variant 37.7 ± 0.8 46.8 ± 0.2 9.1
MBP-OLF(I477S) Disease-causing variant 39.7 ± 0.2 48.2 ± 0.5 8.5
MBP-OLF(N480K) Disease-causing variant 42.4 ± 0.2 48.1 ± 0.1 5.9
MBP-OLF(P481L) Disease-causing variant 45.5 ± 0.4 51.2 ± 0.3 5.7
MBP-OLF(I499F) Disease-causing variant 42.8 ± 0.1 50.4 ± 0.4 7.6
MBP-OLF(S502P) Disease-causing variant 41.0 ± 0.3 49.9 ± 0.2 8.9

a From Ref. 27.

b Variant could not be purified in sufficient quantities in folded state for measurement.